MarketCap
Facebook
X
TelegramQuartalsbericht 2022-Q3
hinzugefügt 21.11.2022
Applied Genetic Technologies Corporation Current Ratio 2011-2026 | AGTC
Current Ratio Jährlich Applied Genetic Technologies Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.79 | 3.08 | 3.42 | 9.01 | 7.58 | 4.63 | 1.87 | 13.8 | 29.8 | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 29.8 | 1.79 | 8.33 |
Current Ratio Vierteljährlich Applied Genetic Technologies Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 1.44 | 1.79 | 2.17 | 2.26 | 2.7 | 3.08 | 3.08 | 2.36 | 2.91 | 3.42 | 3.42 | 3.7 | 5.08 | 6.83 | 6.83 | 3.36 | 3.06 | 6.13 | 6.13 | 6.65 | 5.9 | 4.54 | 4.54 | 3.46 | 2.94 | 2.53 | 2.53 | 2.08 | 1.86 | 19.4 | 19.4 | 37 | 32.5 | 30.6 | 30.6 | - | 7.14 | 7.14 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 37 | 1.44 | 7.85 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Graybug Vision
GRAY
|
0.672 | - | -11.23 % | $ 9.65 M |  USA |
 |
Apellis Pharmaceuticals
APLS
|
1.52 | $ 20.16 | -2.61 % | $ 2.54 B | USA |
 |
Aptorum Group Limited
APM
|
3.71 | $ 0.79 | -6.17 % | $ 4.31 M |  China |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Acer Therapeutics
ACER
|
0.41 | - | 2.71 % | $ 14 M | USA |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
AbCellera Biologics
ABCL
|
3.48 | $ 3.71 | -2.88 % | $ 1.11 B |  Canada |
 |
Athersys
ATHX
|
2.38 | - | 3.77 % | $ 22.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
2.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
1.77 | - | - | $ 521 M | USA |
 |
Axsome Therapeutics
AXSM
|
1.15 | $ 164.05 | -1.4 % | $ 8.16 B | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
0.191 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | USA |
 |
Burford Capital Limited
BUR
|
2.14 | $ 8.55 | -2.06 % | $ 1.39 B | Britain |
 |
BridgeBio Pharma
BBIO
|
0.311 | $ 64.53 | -1.48 % | $ 12.4 B | USA |
 |
Adverum Biotechnologies
ADVM
|
1.65 | - | - | $ 86.2 M | USA |
 |
CymaBay Therapeutics
CBAY
|
3.05 | - | - | $ 3.45 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
1.22 | - | - | $ 789 M | USA |
 |
ARCA biopharma
ABIO
|
28.7 | - | 1052.0 % | $ 415 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
5.04 | $ 58.53 | -2.03 % | $ 11.2 B | USA |
 |
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
6.16 | - | -16.75 % | $ 25.8 M | USA |
 |
Alpine Immune Sciences
ALPN
|
2.67 | - | - | $ 2.17 B | USA |
 |
Clovis Oncology
CLVS
|
0.629 | - | -7.23 % | $ 13 M | USA |
 |
Acorda Therapeutics
ACOR
|
1.61 | - | -24.86 % | $ 820 K | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
8.41 | - | - | $ 231 M | USA |
 |
Acasti Pharma
ACST
|
13.4 | - | 4.01 % | $ 150 M | Canada |
 |
CTI BioPharma Corp.
CTIC
|
0.878 | - | - | $ 1.2 B | USA |
 |
CohBar
CWBR
|
15.8 | - | -15.44 % | $ 2.2 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
0.653 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
0.653 | - | -4.36 % | $ 27 M | USA |
 |
Cabaletta Bio
CABA
|
14.5 | $ 3.25 | -1.52 % | $ 3.8 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.86 | - | - | $ 2.18 B | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
Capricor Therapeutics
CAPR
|
1.63 | $ 25.84 | -3.8 % | $ 692 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.6 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
1.81 | - | -10.17 % | $ 12.2 K | USA |
 |
Codexis
CDXS
|
1.82 | $ 0.98 | -3.92 % | $ 71.9 M | USA |
 |
Certara
CERT
|
3.15 | $ 7.24 | 2.7 % | $ 1.16 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
4.22 | - | - | $ 105 M | USA |
 |
Evofem Biosciences
EVFM
|
0.146 | - | 7.55 % | $ 38.1 M | USA |
 |
Coherus BioSciences
CHRS
|
0.765 | $ 1.65 | - | $ 155 M | USA |
 |
Evelo Biosciences
EVLO
|
0.928 | - | -14.46 % | $ 27.9 M | USA |